Literature DB >> 3793932

Complementation analysis of fatty acid oxidation disorders.

A Moon, W J Rhead.   

Abstract

We assayed [9,10(n)-3H]palmitate oxidation by fibroblast monolayers from patients with fatty acid oxidation disorders. Activities in the different disorders were (percent control): short-chain acyl-coenzyme A (CoA) dehydrogenase deficiency (115%), medium chain acyl-CoA dehydrogenase deficiency (18%), long-chain acyl-CoA dehydrogenase deficiency (28%), multiple acyl-CoA dehydrogenation disorder, mild and severe variants (49% and 7%), and palmityl-carnitine transferase deficiency (4%). Multiple acyl-CoA dehydrogenation disorder, medium chain acyl-CoA dehydrogenase-deficient lines, and long-chain acyl-CoA dehydrogenase-deficient lines all complemented one another after polyethylene glycol fusion, with average activity increases of 31-83%. We detected two complementation groups in the severe multiple acyl-CoA dehydrogenation disorder lines, consistent with deficiencies of either electron transfer flavoprotein or electron transfer flavoprotein:ubiquinone oxidoreductase. The metabolic block in the latter cell lines is threefold more severe than in the former (P less than 0.001). No intragenic complementation was observed within either group. We assigned two patients with previously unreported severe multiple acyl-CoA dehydrogenation disorder to the electron transfer flavoprotein:ubiquinone oxido-reductase-deficient group.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3793932      PMCID: PMC423985          DOI: 10.1172/JCI112808

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Fluorometric assay of proteins in the nanogram range.

Authors:  P Böhlen; S Stein; W Dairman; S Udenfriend
Journal:  Arch Biochem Biophys       Date:  1973-03       Impact factor: 4.013

2.  Glutaric acidemia type II: clinical, biochemical, and morphologic considerations.

Authors:  S I Goodman; D O Stene; E R McCabe; M D Norenberg; R H Shikes; D A Stumpf; G K Blackburn
Journal:  J Pediatr       Date:  1982-06       Impact factor: 4.406

3.  Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency.

Authors:  P F Bougnères; J M Saudubray; C Marsac; O Bernard; M Odièvre; J Girard
Journal:  J Pediatr       Date:  1981-05       Impact factor: 4.406

4.  Glutaric aciduria type II: report on a previously undescribed metabolic disorder.

Authors:  H Przyrembel; U Wendel; K Becker; H J Bremer; L Bruinvis; D Ketting; S K Wadman
Journal:  Clin Chim Acta       Date:  1976-01-16       Impact factor: 3.786

5.  Neonatal glutaric aciduria type II: an X-linked recessive inherited disorder.

Authors:  F X Coude; H Ogier; C Charpentier; G Thomassin; A Checoury; O Amedee-Manesme; J M Saudubray; J Frezal
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

6.  Dicarboxylic aciduria: deficient [1-14C]octanoate oxidation and medium-chain acyl-CoA dehydrogenase in fibroblasts.

Authors:  W J Rhead; B A Amendt; K S Fritchman; S J Felts
Journal:  Science       Date:  1983-07-01       Impact factor: 47.728

7.  Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation.

Authors:  J M Saudubray; F X Coudé; F Demaugre; C Johnson; K M Gibson; W L Nyhan
Journal:  Pediatr Res       Date:  1982-10       Impact factor: 3.756

8.  Biochemical studies in a patient with defects in the metabolism of acyl-CoA and sarcosine: another possible case of glutaric aciduria type II.

Authors:  N Gregersen; S Kølvraa; K Rasmussen; E Christensen; N J Brandt; F Ebbesen; F H Hansen
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

9.  Ethylmalonic-adipic aciduria. In vivo and in vitro studies indicating deficiency of activities of multiple acyl-CoA dehydrogenases.

Authors:  S Mantagos; M Genel; K Tanaka
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

10.  Recurrent hypoglycemia associated with glutaric aciduria type II in an adult.

Authors:  G Dusheiko; M C Kew; B I Joffe; J R Lewin; S Mantagos; K Tanaka
Journal:  N Engl J Med       Date:  1979-12-27       Impact factor: 91.245

View more
  39 in total

1.  A simple screening test for fatty acid oxidation defects using whole-blood palmitate oxidation.

Authors:  L E Seargeant; K Balachandra; C Mallory; L A Dilling; C R Greenberg
Journal:  J Inherit Metab Dis       Date:  1999-08       Impact factor: 4.982

2.  BNip3 regulates mitochondrial function and lipid metabolism in the liver.

Authors:  Danielle Glick; Wenshuo Zhang; Michelle Beaton; Glenn Marsboom; Michaela Gruber; M Celeste Simon; John Hart; Gerald W Dorn; Matthew J Brady; Kay F Macleod
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

3.  Riboflavin responsive ethylmalonic-adipic aciduria in a 9-month-old boy with liver cirrhosis, myopathy and encephalopathy.

Authors:  M Brivet; M Tardieu; A Khellaf; A Boutron; F Rocchiccioli; C A Haengeli; A Lemonnier
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

4.  A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts.

Authors:  N J Manning; S E Olpin; R J Pollitt; J Webley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 5.  Compromised fatty acid oxidation in mitochondrial disorders.

Authors:  L Hagenfeldt
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

6.  Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats.

Authors:  Ling Shen; Ye Xiong; David Q-H Wang; Philip Howles; Joshua E Basford; Jiang Wang; Yu Qing Xiong; David Y Hui; Stephen C Woods; Min Liu
Journal:  J Lipid Res       Date:  2013-02-22       Impact factor: 5.922

7.  Sex-specific, reciprocal regulation of ERα and miR-22 controls muscle lipid metabolism in male mice.

Authors:  Judith Schweisgut; Christian Schutt; Stas Wüst; Astrid Wietelmann; Bart Ghesquière; Peter Carmeliet; Stefan Dröse; Kenneth S Korach; Thomas Braun; Thomas Boettger
Journal:  EMBO J       Date:  2017-03-17       Impact factor: 11.598

8.  Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.

Authors:  J L Van Hove; W Zhang; S G Kahler; C R Roe; Y T Chen; N Terada; D H Chace; A K Iafolla; J H Ding; D S Millington
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

9.  Fatty acid oxidation in fibroblasts from patients with defects in beta-oxidation and in the respiratory chain.

Authors:  N Venizelos; U von Döbeln; L Hagenfeldt
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

10.  Acyl-CoA-binding protein (ACBP) can mediate intermembrane acyl-CoA transport and donate acyl-CoA for beta-oxidation and glycerolipid synthesis.

Authors:  J T Rasmussen; N J Faergeman; K Kristiansen; J Knudsen
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.